We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-1.54%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$83.7B
AUM Growth
-$1.57B
Cap. Flow
-$3.66B
Cap. Flow %
-4.37%
Top 10 Hldgs %
8.74%
Holding
5,820
New
545
Increased
1,802
Reduced
1,597
Closed
678

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$365M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$307M
3
ADBE icon
Adobe
ADBE
+$250M
4
NVDA icon
NVIDIA
NVDA
+$242M
5
CRM icon
Salesforce
CRM
+$240M

Sector Composition

Rank Sector Weight
1 Technology 13.15%
2 Financials 9.51%
3 Healthcare 7.52%
4 Consumer Discretionary 6.79%
5 Communication Services 5.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORIA
4226
DELISTED
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
$249K ﹤0.01%
+25,301
New +$248K
CNS icon
4227
Cohen & Steers
CNS
$4.27B
$248K ﹤0.01%
+3,953
New +$283K
RDVT icon
4228
Red Violet
RDVT
$1.11B
$248K ﹤0.01%
14,342
-7,667
-35% -$153K
TALK
4229
DELISTED
Talkspace
TALK
$248K ﹤0.01%
240,449
-358,109
-60% -$526K
VICI icon
4230
VICI Properties
VICI
$28.9B
$248K ﹤0.01%
8,311
-364,275
-98% -$12M
ADV icon
4231
Advantage Solutions
ADV
$432M
$247K ﹤0.01%
4,638
+2,675
+136% +$247K
ENTA icon
4232
Enanta Pharmaceuticals
ENTA
$410M
$246K ﹤0.01%
4,741
NG icon
4233
NovaGold Resources
NG
$4.29B
$246K ﹤0.01%
52,552
-49,854
-49% -$231K
TSVT
4234
DELISTED
2seventy bio
TSVT
$245K ﹤0.01%
+16,866
New +$250K
XERS icon
4235
Xeris Biopharma Holdings
XERS
$1.59B
$245K ﹤0.01%
157,255
+108,392
+222% +$179K
PANA
4236
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$245K ﹤0.01%
25,008
VERV
4237
DELISTED
Verve Therapeutics
VERV
$243K ﹤0.01%
7,062
-87,063
-92% -$2.78M
DM
4238
DELISTED
Desktop Metal, Inc.
DM
$243K ﹤0.01%
9,399
-48,834
-84% -$1.37M
ALXO icon
4239
ALX Oncology
ALXO
$277M
$241K ﹤0.01%
25,223
-9,163
-27% -$107K
PEBO icon
4240
Peoples Bancorp
PEBO
$1.42B
$241K ﹤0.01%
+8,332
New +$245K
IMTXW
4241
DELISTED
Immatics N.V. Warrants
IMTXW
$240K ﹤0.01%
88,599
+698
+0.8% +$2.18K
ELVT
4242
DELISTED
Elevate Credit, Inc.
ELVT
$240K ﹤0.01%
218,125
-162,842
-43% -$295K
INNV icon
4243
InnovAge Holding
INNV
$1.48B
$239K ﹤0.01%
40,632
-18,404
-31% -$84.2K
RICK icon
4244
RCI Hospitality Holdings
RICK
$232M
$238K ﹤0.01%
+3,647
New +$227K
ECL icon
4245
Ecolab
ECL
$81.2B
$237K ﹤0.01%
1,639
-43,138
-96% -$7M
SPWR
4246
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
$237K ﹤0.01%
+10,300
New +$232K
CSR
4247
PUT
Centerspace
CSR
$905M
$236K ﹤0.01%
+3,500
New +$278K
WB icon
4248
CALL
Weibo
WB
$1.75B
$236K ﹤0.01%
13,800
-19,300
-58% -$373K
XAGE
4249
DELISTED
Longevity Health Holdings, Inc. Common Stock
XAGE
$236K ﹤0.01%
811
JBSS icon
4250
John B. Sanfilippo & Son
JBSS
$875M
$235K ﹤0.01%
3,108

Similar funds

David Shaw's Q3 2022 Portfolio in Review

As of Q3 2022, David Shaw held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

David Shaw withdrew a net $3.66B in Q3 2022, closing 678 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, David Shaw opened a new position in Prologis worth $66.1M.

  • David Shaw's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
  • David Shaw added most to Visa in Q3 2022, an estimated $365M increase.
  • David Shaw's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
  • David Shaw fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
  • David Shaw's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
  • David Shaw opened 545 new positions and closed 678 in Q3 2022.
  • David Shaw's portfolio value fell 1.8% quarter-over-quarter to $83.7B.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.